Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Glaxo aims to boost prospects of four promising cancer drugs

Article Abstract:

GlaxoSmithKline PLC of the United Kingdom is developing four new cancer drugs to capture a larger market share in cancer drug sales. The pharmaceutical company had revenues of 1 billion Pounds ($1.72 billion) for cancer products or approximately five percent of its 20.35 billion Pounds in total sales. GlaxoSmithKline PLC, although the second largest pharmaceutical company by sales, ranks 11th in the sale of cancer products.

Author: Whalen, Jeanne
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
Product development, Sales, profits & dividends, Pharmaceutical preparations, Pharmaceutical industry, Company sales and earnings, Company earnings/profit, Company Profile, GlaxoSmithKline PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


With U.S. methods, Britain posts gains in fighting poverty: tax credits, minimum wage help poor children in U.K. but critics see trade-offs; concern over budget deficit

Article Abstract:

British P rime M inister Tony Blair's policies have resulted in a drop i n the number of poor children in the United Kingdom. Although Mr. Blair has based his policies on those of the United States, poverty in the U.S. hasn't decreased significantly in the past decade. Mr. Blair's critics, however, are concerned about budget deficits, and on creating a system of dependency on government.

Author: Whalen, Jeanne, Nelson, Emily
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
United States, Forecasts, trends, outlooks, Public affairs, Taxes, Social aspects, Economic aspects, Forecasts and trends, Blair, Tony, Social policy, Market trend/market analysis, Poverty, Tax policy, Poor children

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Britain stirs outcry by weighing benefits of drugs versus price

Article Abstract:

The health policy of the United Kingdom weighs benefits against costs and has decided to discontinue funding for Alzheimer's medication. Alzheimer's drugs may delay the worsening of the disease in some patients. Alzheimer's patients are protesting through the Alzheimer's Society.

Author: Whalen, Jeanne
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
Accident & Health Insurance, Insurance Carriers, Direct Health and Medical Insurance Carriers, Hospital and medical service plans, Medical Care Insurance, Drug therapy, Health insurance, Alzheimer's disease, Medical policy, Health policy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United Kingdom
Similar abstracts:
  • Abstracts: VW's woes mount amid claims of sex junkets for union chiefs. Daimler fires workers following its bribery probe
  • Abstracts: Sony aims at Microsoft in online games: PlayStation service offers 3-D socializing in race with Wii, Xbox. TiVo plans to allow unlimited tv-show downloads to iPods
  • Abstracts: China's car makers break out of the pack. Can the new-look Malibu help jump-start Chevy? Toyota maps plan to displace GM as top car maker
  • Abstracts: CME ends Polish foray with sale of TVN stake. Europe's defense firms aim at U.S. Change in rules needed for wake of big new jet
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.